Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07160790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 8, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Trial Details
NCT Number NCT07160790
Lead Sponsor Onconic Therapeutics Inc.
Conditions
(from sponsor)
Non-erosive Gastroesophageal Reflux Disease
Related terms Non-Erosive Reflux Disease
Enrollment 321 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov